The use of auditory brainstem response (ABR) for assessment of hearing in the neonate has not been without challenge. Although numerous articles have appeared, agreement regarding the utility of neonatal ABR testing does not exist. In review of the current studies and commentaries, a clear majority are favorable to neonatal ABR testing. These studies along with current test procedures are discussed. (38); procedures for the assessment of that potential were initiated. Since 1975, the research reported in the literature has grown exponentially each year. In spite of the large and increasing amount of research reported, sever! issues have remained unresolved, viz., the applicability, reliability, and validity of neonatal ABR testing. In fact, because of these and other factors, some authors have begun to seriously question using ABR with neonates (13, 35, 42) .
the potential of accurate evaluation of auditory function in the neonate has existed. With the subsequent reporting of use in the NICU in 1975 by Schulman-Galambos and Galambos (38) ; procedures for the assessment of that potential were initiated. Since 1975, the research reported in the literature has grown exponentially each year. In spite of the large and increasing amount of research reported, sever! issues have remained unresolved, viz., the applicability, reliability, and validity of neonatal ABR testing. In fact, because of these and other factors, some authors have begun to seriously question using ABR with neonates (13, 35, 42) .
. The need for early identification of infants with hearing loss is apparent. Normal language, learning, and social skill acquisition is contingent upon hearing. Although the incidence of hearing impairment in the general neonatal population is relatively low (0,26%) (41), in NICU neonates the incidence is considerably higher (2-10%) (16, 39) . Furthermore, the improved survival rate of neonates born weighing less than 1500 g (19, 31) has increased the pool of infants in which a high incidence of hearing impairment is seen (16) . Because the need for early identification of hearing loss does exist and the current procedures that could identify hearing impairment in the neonate are open to question (ABR), a critical review of ABR testing is in order. The purpose of this article is to summarize the current ABR literature, both pro and con, and to draw conclusions regarding its use based on the literature and the experience of the writer. The summary will not attempt to review early ABR literature primarily due to excellent reviews that are already published. The interested reader, however, would find Downs (13) very thorough.
The current literature pertinent to ABR testing of neonates and NICU populations is discussed and from several aspects (5) (6) (7) II, 12, 17, 20, 25, 34, 36, 47 (27) , Marshall et al. (29) , Hecox and Cone (21), Hecox et al. (20) , Cox et al. (8) , and Roberts et al. (35) . ABR as a screening tool has been reported by Homing (24), Crowell et al. (9) , Hecox et al. (20) , and Salamy et al. (37) , while Simmons (43) and Galambos et al. (17) have compared ABR with Crib-O-Gram testing. These citations illustrate some of the current literature that is pertinent to neonatal ABR testing. In the following sections, specific aspects are discussed separately . TEST 
PROTOCOL
The ABR protocol has undergone many refinements, a number of which have been facilitated by advances in commercial equipment. Factors considered in discussing current protocols include placement of the electrode, selection of intensity levels, test environment, state of the neonate, nature of the stimulus, and rate of nresentation.
The most popular electrode configuration has usually been vertex (Cz) active with ipsilateral mastoid or earlobe reference and contralateral mastoid or earlobe as ground (2, 4, 9, 12, 20, 27, 34, 36) . With possible fontanel problems, however, several authors have found forehead placement of the active electrode instead of the vertex to be effective and simple (7, 18,25,28-30, 32, 33, 35) .
Intensity levels are typically designated as normal hearing level (as before a jury of normal listeners), hearing level (corresponds to manufacturer's dial reading), sound pressure level (0.0002 dyne/em"), sensation level (amount of intensity above individual threshold), and peak equivalent (equivalent amplitude of pure tone on oscilliscopic display). For simplicity sake, normal hearing level is best to use with periodic rechecks either behaviorally or with sound pressure level measure once normal hearing level has been determined.
The test environment and condition of the subject are important and can influence the results. Generally ABR testing (screening) can be done in the nursery. If testing occurs in the NICU, it is important that it be done when the neonate is stable (in room air, free from respiratory disturbances, etc.). Testing can occur in other areas in the NICU and when the subject is acutely ill, but as will be discussed later, the reliability of the procedure is reduced. If the infant is attached to monitors , IVs, etc., some electrical interference can occur and may require temporary shutdown of this equipment or repositioning the subject. Ambient noise can also be a problem due to differential effects on the various waveform components (44) . Early ABR components (Wave I) do not appear to be affected by noise while the later components (Wave V) exhibit increased latencies (45) . It is desirable when testing in the NICU to obtain ABR data at low levels of ambient noise. This on occasion may require testing in an adjacent room.
Stimuli typically consist of clicks of IOO-msec duration. Although click polarity can affect waveform latency and morphology (45), the literature is unresolved with regards to preference for condensation or rarefaction polarity (22) . It has been shown, however, that very adquate waveform reproduction can be obtained with alternating polarity clicks and in addition there is a reduction in stimulus artifact (6) (7) (8) 25) .
The rate of stimulus presentation varies from 10 (25) to 38 (47) per sec. With faster presentation rates, peak definition is degraded, Wave I amplitude is reduced, and ABR threshold may be increased in premature infants (8) . A good compromise between test speed and wave identification is 21/sec which is generally satisfactory (28) .
Normative data. Several studies have reported normative values for neonates (5, 6, II , 15, 22, 25, 28, 45, 47) . The general purpose has been to determine what the expected responses are in order that abnormal or atypical findings become apparent. However, a caveat must be issued if one expects to use the published norms for their particular equipment, environment, and population : a considerble number of individual or combined factors are unique to each test setting. These factors interact to influence a response such that each setting will have different normal response values. Published norms can be used for comparison purposes but according to Weber (47) not transposed as exact values to other test settings. Therefore, it is imperative that each setting determine its own normative data.
Risk factors. A number of perinatal events are thought to be associated with hearing loss, e.g., low birth weight, hyperbilirubinemia, asphyxia, acidosis, aminoglycoside drug therapy, intracranial hemorrhage, hyaline membrane disease. Several studies have been published which have attempted to isolate these individual factors and correlate their respective effects on auditory function via the ABR response, (2, 8, 15, 20, 21, 27, 29, 35) . As of yet, however, relationships between ABR-determined hearing impairment and specific risk factors are tenuous at best. If combined factors are looked at, however, they appear to be highly predictive of ABR-determined impairment (8) . In essence, the more risk factors involved, the more likely the neonate will have abnormal ABR results.
Screening. The American Academy of Pediatrics Joint Committee on Infant Hearing published their most recent position statement in September 1982 (1). Within the statement, the use of behavioral or electrophysiologicprocedures was recommended in early identification of hearing impairment. Studies detailing ABRas a screening tool (9,14,24,37,39) have generally reported that it meets the screening criteria and is a reliable tool.
The screening procedure typically consists of testing in the nursery at two levels of intensity: one high and one low (60-70 and 30-40 dB). Failure criteria consist of absence of a response at either intensity. Recently, Roberts et al. (35) suggested that 50% of neonates may fail at 40 dB. This would suggest that a 40-dB level is somewhat insensitive in identifying normal versus abnormal function . However, Weber (47) found consistent responses at 30 dB in 130 of 200 subjects and Lee and Cox (28) found consistent responses at 40 dB in 100% of their subjects. Although a 40-dB level can be used, it decreased the sensitivity of the test (47) . Screening levels of 30 and 60 dB appear to be most efficient.
Failures from the screening should be referred for follow-up testing while additional testing of neonates who pass the screening is unwarranted. There are however, exceptions to this format , e.g., subsequent intracranial hemorrhage or meningitis, etc. The time period for follow-up testing of failures is critical. Maturational changes and resolution of transient problems may not be seen if retesting occurs too soon, thereby prolonging a high false positive rate. On the other hand, if retesting is delayed too long, valuable time that is critical for habilitation will be lost. The optimum time for ABR retesting appears to be at 3-4 months of age. A word of warning is in order: subsequent ABR testing in isolation is hazardous. Behavioral and impedance testing should be used in concert with ABR to determine auditory function (6, 46, 48) .
. Reliability. Of all aspects associated with ABR testing, reliability is perhaps one of the least documented and , as of late, most questioned . A major difficulty with determining the reliability of ABR testing is that the auditory system is not mature at birth and affects the ABR response commensurately. Coupled with the ongoing maturation are the various factors discussed previously which may affect the ABR response when occurring but not after resolution.
The incidence of reported NICU ABR abnormality is approximately 15% (17, 24, 32) . Subsequent retesting after hospital discharge produces considerably lower figures, i.e., 2-8% (7, 15). The reported incidence of substantial hearing loss in the same population appears to be around 2% (17, 39, 42) . The false positive rate, then, may approximate 13%. This per cent difference between test-retest reflects what appears to be a false positive rate which may lead to questioning the reliability of ABR. If one compares ABR with other screening procedures like COG, the false positive rate does not seem unusual. For example, Wright and Rybak (49) reported the false positive rate for COG in a NICU population was 80%. With new test procedures, more experience, and close attention to test environment and status of the subject, the false positive rate could realistically be reduced to a single digit percentage. For example, Hooks and Weber (23) report that with bone conduction stimuli the overall failure rate with ABR in the NICU is 2-3%. This failure rate approximates the incidence of hearing loss in the NICU population.
Although the false positive rate may appear to be relatively high, the false negative rate is not known. As near as the present writer is able to determine , however, a single false negative case is yet to be firmly identified.
The initial ABR failures which subsequently pass may indeed reflect abnormality at the time of initial testing. These abnormalities may be related to problems in later development , particularly those aspects associated with learning. If this is demonstrated to be the case, then early ABR data could have predictive significance for later development.
To abandon ABR testing at this time because questions of reliability have not as yet been resolved would be foolishly premature, especially since other available contemporary procedures are not better and certainly are not as sensitive as ABR, e.g., identifying unilateral loss or mild to moderate hearing loss (8, 17, 49) . In view of the alternatives to ABR testing, and the potential of assessment that does exist, continued ABR testing in risk and NICU populations is certainly warranted as are follow-up studies to further establish the ABR as a routine procedure.
There are other reasons not to abandon ABR testing but they are less concrete although further research may demonstrate applicability. Many congenital or perinatal metabolic and neurologic disorders can produce changes that affect the developing brain. Since the ABR is sensitive to structural integrity, early diagnosis and lesion localization may be facilitated by ABR testing (44) .
A point needs to be discussed regarding ABR versus other procedures like the COG or the Linco-Bennett auditory response cradle. These seem to be the only two types of procedures available for NICU or nursery testing and it appears that a choice has to be made between the two because they are not compatible. That assumption is incorrect. The COG and response cradle procedures measure the number of physical responses a neonate makes to a loud stimuli (3, 30, 40) . Information for separate ears is not obtainable and mild and moderate hearing loss can be missed. The factors which make the COG and response cradle attractive are cost and time. A large number of neonates can be tested in a short time relatively inexpensively.
The ABR procedure is different from the COG and response cradle in that the response is electrophysiologic in nature. Information about separate ears, neurologic impairment, and hearing sensitivity can be obtained (17) . The major stumbling block to universal use has been cost of equipment and train ed test personnel. The equipment cost at present is less prohibitive than in recent years, however, Manufacturers are now designing and producing equipment that is smaller in size, considerably lower in price and yet very adequate for ABR testing in the NICU . The trained personnel shortage is less acute since training programs are now incorporating ABR coursework in their curricula and with the widespread growth of ABR in the NICU, practicum and training sites are now available. In the very near future, the major stumbling blocks mentioned previously may well be eliminated.
Currently there is an alternative approach to the problem of cost and test personnel. Davis (10) and others (33, 37) have reported that the Infant Hearing Assessment Program is a means whereby neonates can be tested with ABR at a minimal cost. The Infant Hearing Assessment Foundation is a nonprofit organization devoted to identifying hearing loss in infants (37) . The foundation provides both equipment and test personnel to the hospital which makes inexpensive ABR testing feasible. As of yet, however, the validity of the procedure and the reliability of equipment are yet to be established in referred publications.
In the literature reviewed for the current article, an overwhelming majority of the articles have been favorable in regard to NICU and at-risk neonate testing. This does not necessarily validate the ABR procedure since the literature has not been unanimous in support of neonatal ABR testing (13, 35, 43) . While a difference in opinion is healthy, a closer look at the rationale presented by those opposed would be helpful in a final judgment regarding ABR use. Downs (13) in his review of ABR has suggested a cautious approach to neonatal ABR testing. The present writer is certainly in agreement and would strongly reinforce caution in ABR testing. With experience, however, this writer and those who have been using ABR with neonates for a similar length of time, have found that the procedure has been reliable and predictive of auditory disorder.
In response to Roberts et al. (35) who questioned the effectiveness of neonatal ABR, their data warrant close inspection . The average age of the infants at the time of ABR testing was 30 weeks gestation. Many of the infants were acutely ill and still on assisted ventilation. Very few screening programs follow this practice. In general, ABR testing is done just prior to discharge when the infant is in a room and free from respiratory disturbances (5). Testing accomplished when infants are still very young and before they have stabilized can affect the ABR results (8) and is ill-advised.
Also, out of an initial test population of 75 subjects, 44 were classified as ABR failures. Of these 44 failures, only 10 were actually subsequently tested. To make conclusions regarding the effectiveness of a procedure with such limited follow-up testing is fallacious. Furthermore, Davis, the second author of Roberts et aI., has stated that ABR is an effective tool for neonatal testing (10) .
Simmons (43) cnucizes neonatal ABR use because of the practice of labeling initial failures (15%) as being hearing impaired. The present writer is certainly in agreement with this but would advise not to discontinue ABR testing, but to discontinue the labeling. The determination or pronouncement of hearing impairment should not be made until follow-up ABR and behavioral testing has occurred. In fact, it has been the experience of this writer that determination of a hearing impairment and the subsequent fitting of a hearing aid before 4 months of age is at best tenuous.
SUMMARY
Although neonatal ABR testing is not without opposition , the majority of the literature supports its use. If a cautious approach is used, i.e., testing when the infant is stable, monitoring environmental conditions, obtaining individual norms, and allowing only qualified personnel (trained and experienced) to test, the ABR procedure can be a powerful tool in positively identifying hearing loss at a very early age. The ABR procedure is by no means perfected at this point and additional research is ongoing. In the opinion of this writer, however, additional research will ony add to the sensitivity and diagnostic power of the test.
